Upgrade to SI Premium - Free Trial

Bristol-Myers Squibb Co. (BMY) PT Lowered to $60 at Wells Fargo

October 13, 2026 5:55 AM
Wells Fargo analyst Mohit Bansal lowered the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $65.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change